4//SEC Filing
Gasser Elizabeth Anne 4
Accession 0001438133-25-000212
CIK 0001438133other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:06 PM ET
Size
16.6 KB
Accession
0001438133-25-000212
Insider Transaction Report
Form 4
Gasser Elizabeth Anne
EVP, Chief Strategy Officer
Transactions
- Tax Payment
Common Stock
2025-11-17$18.61/sh−587$10,924→ 3,000 total - Exercise/Conversion
Restricted Stock Unit
2025-11-17−1,503→ 3,006 total→ Common Stock (1,503 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-11-17−1,096→ 6,581 total→ Common Stock (1,096 underlying) - Tax Payment
Common Stock
2025-11-17$18.61/sh−805$14,981→ 2,491 total - Award
Common Stock
2025-11-17$15.59/sh+586$9,136→ 1,793 total - Exercise/Conversion
Common Stock
2025-11-17+1,096→ 3,587 total - Exercise/Conversion
Common Stock
2025-11-17+1,503→ 3,296 total
Holdings
- 22,949(indirect: See Footnote)
Common Stock
Footnotes (8)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2025, through November 17, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F2]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.
- [F4]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F5]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F6]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F7]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F8]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001866283
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:06 PM ET
- Size
- 16.6 KB